Navigation Links
EraGen strikes big distribution deal; Berbee buys again

A small Madison biotech firm, EraGen Biosciences, has just forged a worldwide distribution conduit for one of its products. The firm exclusively licensed rights to its test for cystic fibrosis, a genetic lung disease, to pharma giant Bayer Healthcare. Also: Berbee Information Networks Corporation has bought another IT firm, this one in Appleton.

Original air date: Saturday, May 21, 2005
Full article >>>
'"/>

Source:wistechnology.com By Mike Klein 05/21/05


Page: 1

Related biology technology :

1. EraGen set to highlight diagnostic products at BIO
2. EraGen diagnostic passes UW tests, could quickly detect bird flu
3. EraGen lands $12 million venture round
4. EraGen gets $250,000 state loan to revamp manufacturing facility
5. EraGen cystic fibrosis test to be distributed worldwide through Bayer
6. EraGens SARS test validated by Chinese agency
7. EraGen collaborates with Emory University on HIV detection system
8. EraGen signs Canadian Market Distribution Agreement for nucleic acid dection products
9. Promega and EraGen sign technology licensing agreement
10. EraGens Revolutionary Genomic-Based Technologies
11. EraGen Expands in Japan
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology:
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):